Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours

Irene Bottillo, Terje Ahlquist, Helge Brekke, Stine A. Danielsen, Eva Den Van Berg, Fredrik Mertens, Ragnhild A. Lothe, Bruno Dallapiccola

Research output: Contribution to journalArticle

84 Citations (Scopus)

Abstract

Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequency in patients with neurofibromatosis type 1 (NF1). In contrast to the well-known spectrum of germline NFI mutations, the information on somatic mutations in MPNSTs is limited. In this study, we screened NFI, KRAS,and BRAF in 47 MPNSTs from patients with (n = 25) and without (n = 22) NF1. In addition, DNA from peripheral blood and cutaneous neurofibroma biopsies from, respectively, 14/25 and 7/25 of the NF1 patients were analysed. Germline NFI mutations were detected in ten NF1 patients, including three frameshift, three nonsense, one missense, one splicing alteration, and two large deletions. Somatic NFI mutations were found in 10/25 (40%) NF1-associated MPNSTs, in 3/7 (43%) neurofibromas, and in 9/22 (41%) sporadic MPNSTs. Large genomic copy number changes accounted for 6/10 and 7/13 somatic mutations in NF1-associated and sporadic MPNSTs, respectively. Two NF1-associated and 13 sporadic MPNSTs did not show any NFI mutation. A major role of the KRAS and BRAF genes was ruled out. The spectrum of germline NFI mutations in neurofibromatosis patients with MPNST is different from the spectrum of somatic mutations seen in MPNSTs. However, the somatic events share common characteristics with the NF1-related and the sporadic tumours.

Original languageEnglish
Pages (from-to)693-701
Number of pages9
JournalJournal of Pathology
Volume217
Issue number5
DOIs
Publication statusPublished - Apr 2009

Fingerprint

Neurilemmoma
Neurofibromatosis 1
Mutation
Germ-Line Mutation
Neurofibroma
Neurofibromatoses
Neoplasms
Biopsy
Skin
DNA

Keywords

  • DHPLC
  • Malignant peripheral nerve sheath tumour
  • MLPA
  • MPNST
  • Neurofibromatosis 1
  • NF1

ASJC Scopus subject areas

  • Pathology and Forensic Medicine
  • Medicine(all)

Cite this

Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours. / Bottillo, Irene; Ahlquist, Terje; Brekke, Helge; Danielsen, Stine A.; Van Berg, Eva Den; Mertens, Fredrik; Lothe, Ragnhild A.; Dallapiccola, Bruno.

In: Journal of Pathology, Vol. 217, No. 5, 04.2009, p. 693-701.

Research output: Contribution to journalArticle

Bottillo, I, Ahlquist, T, Brekke, H, Danielsen, SA, Van Berg, ED, Mertens, F, Lothe, RA & Dallapiccola, B 2009, 'Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours', Journal of Pathology, vol. 217, no. 5, pp. 693-701. https://doi.org/10.1002/path.2494
Bottillo I, Ahlquist T, Brekke H, Danielsen SA, Van Berg ED, Mertens F et al. Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours. Journal of Pathology. 2009 Apr;217(5):693-701. https://doi.org/10.1002/path.2494
Bottillo, Irene ; Ahlquist, Terje ; Brekke, Helge ; Danielsen, Stine A. ; Van Berg, Eva Den ; Mertens, Fredrik ; Lothe, Ragnhild A. ; Dallapiccola, Bruno. / Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours. In: Journal of Pathology. 2009 ; Vol. 217, No. 5. pp. 693-701.
@article{997ebba539684f309c81dbe41bdd5fc0,
title = "Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours",
abstract = "Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequency in patients with neurofibromatosis type 1 (NF1). In contrast to the well-known spectrum of germline NFI mutations, the information on somatic mutations in MPNSTs is limited. In this study, we screened NFI, KRAS,and BRAF in 47 MPNSTs from patients with (n = 25) and without (n = 22) NF1. In addition, DNA from peripheral blood and cutaneous neurofibroma biopsies from, respectively, 14/25 and 7/25 of the NF1 patients were analysed. Germline NFI mutations were detected in ten NF1 patients, including three frameshift, three nonsense, one missense, one splicing alteration, and two large deletions. Somatic NFI mutations were found in 10/25 (40{\%}) NF1-associated MPNSTs, in 3/7 (43{\%}) neurofibromas, and in 9/22 (41{\%}) sporadic MPNSTs. Large genomic copy number changes accounted for 6/10 and 7/13 somatic mutations in NF1-associated and sporadic MPNSTs, respectively. Two NF1-associated and 13 sporadic MPNSTs did not show any NFI mutation. A major role of the KRAS and BRAF genes was ruled out. The spectrum of germline NFI mutations in neurofibromatosis patients with MPNST is different from the spectrum of somatic mutations seen in MPNSTs. However, the somatic events share common characteristics with the NF1-related and the sporadic tumours.",
keywords = "DHPLC, Malignant peripheral nerve sheath tumour, MLPA, MPNST, Neurofibromatosis 1, NF1",
author = "Irene Bottillo and Terje Ahlquist and Helge Brekke and Danielsen, {Stine A.} and {Van Berg}, {Eva Den} and Fredrik Mertens and Lothe, {Ragnhild A.} and Bruno Dallapiccola",
year = "2009",
month = "4",
doi = "10.1002/path.2494",
language = "English",
volume = "217",
pages = "693--701",
journal = "Journal of Pathology",
issn = "0022-3417",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Germline and somatic NFI mutations in sporadic and NFI-associated malignant peripheral nerve sheath tumours

AU - Bottillo, Irene

AU - Ahlquist, Terje

AU - Brekke, Helge

AU - Danielsen, Stine A.

AU - Van Berg, Eva Den

AU - Mertens, Fredrik

AU - Lothe, Ragnhild A.

AU - Dallapiccola, Bruno

PY - 2009/4

Y1 - 2009/4

N2 - Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequency in patients with neurofibromatosis type 1 (NF1). In contrast to the well-known spectrum of germline NFI mutations, the information on somatic mutations in MPNSTs is limited. In this study, we screened NFI, KRAS,and BRAF in 47 MPNSTs from patients with (n = 25) and without (n = 22) NF1. In addition, DNA from peripheral blood and cutaneous neurofibroma biopsies from, respectively, 14/25 and 7/25 of the NF1 patients were analysed. Germline NFI mutations were detected in ten NF1 patients, including three frameshift, three nonsense, one missense, one splicing alteration, and two large deletions. Somatic NFI mutations were found in 10/25 (40%) NF1-associated MPNSTs, in 3/7 (43%) neurofibromas, and in 9/22 (41%) sporadic MPNSTs. Large genomic copy number changes accounted for 6/10 and 7/13 somatic mutations in NF1-associated and sporadic MPNSTs, respectively. Two NF1-associated and 13 sporadic MPNSTs did not show any NFI mutation. A major role of the KRAS and BRAF genes was ruled out. The spectrum of germline NFI mutations in neurofibromatosis patients with MPNST is different from the spectrum of somatic mutations seen in MPNSTs. However, the somatic events share common characteristics with the NF1-related and the sporadic tumours.

AB - Malignant peripheral nerve sheath tumours (MPNSTs) are a malignancy occurring with increased frequency in patients with neurofibromatosis type 1 (NF1). In contrast to the well-known spectrum of germline NFI mutations, the information on somatic mutations in MPNSTs is limited. In this study, we screened NFI, KRAS,and BRAF in 47 MPNSTs from patients with (n = 25) and without (n = 22) NF1. In addition, DNA from peripheral blood and cutaneous neurofibroma biopsies from, respectively, 14/25 and 7/25 of the NF1 patients were analysed. Germline NFI mutations were detected in ten NF1 patients, including three frameshift, three nonsense, one missense, one splicing alteration, and two large deletions. Somatic NFI mutations were found in 10/25 (40%) NF1-associated MPNSTs, in 3/7 (43%) neurofibromas, and in 9/22 (41%) sporadic MPNSTs. Large genomic copy number changes accounted for 6/10 and 7/13 somatic mutations in NF1-associated and sporadic MPNSTs, respectively. Two NF1-associated and 13 sporadic MPNSTs did not show any NFI mutation. A major role of the KRAS and BRAF genes was ruled out. The spectrum of germline NFI mutations in neurofibromatosis patients with MPNST is different from the spectrum of somatic mutations seen in MPNSTs. However, the somatic events share common characteristics with the NF1-related and the sporadic tumours.

KW - DHPLC

KW - Malignant peripheral nerve sheath tumour

KW - MLPA

KW - MPNST

KW - Neurofibromatosis 1

KW - NF1

UR - http://www.scopus.com/inward/record.url?scp=64549151639&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=64549151639&partnerID=8YFLogxK

U2 - 10.1002/path.2494

DO - 10.1002/path.2494

M3 - Article

VL - 217

SP - 693

EP - 701

JO - Journal of Pathology

JF - Journal of Pathology

SN - 0022-3417

IS - 5

ER -